These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28809443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of the transport of valproic acid through the blood-brain barrier in rats by the Gastrodia elata extracts.
    Yang L, Lin IH, Ting CT, Tsai TH.
    J Ethnopharmacol; 2021 Oct 05; 278():114276. PubMed ID: 34082013
    [Abstract] [Full Text] [Related]

  • 5. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
    Yamamura N, Imura K, Naganuma H, Nishimura K.
    Drug Metab Dispos; 1999 Jun 05; 27(6):724-30. PubMed ID: 10348803
    [Abstract] [Full Text] [Related]

  • 6. Ultrasonic emulsification of parenteral valproic acid-loaded nanoemulsion with response surface methodology and evaluation of its stability.
    Tan SF, Masoumi HR, Karjiban RA, Stanslas J, Kirby BP, Basri M, Basri HB.
    Ultrason Sonochem; 2016 Mar 05; 29():299-308. PubMed ID: 26585010
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
    Lee SY, Huh W, Jung JA, Yoo HM, Ko JW, Kim JR.
    Drug Des Devel Ther; 2015 Mar 05; 9():4559-63. PubMed ID: 26309401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States.
    Dutta S, Reed RC.
    Epilepsy Res; 2007 Mar 05; 73(3):275-83. PubMed ID: 17208410
    [Abstract] [Full Text] [Related]

  • 13. Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.
    Gynther M, Peura L, Vernerová M, Leppänen J, Kärkkäinen J, Lehtonen M, Rautio J, Huttunen KM.
    Neurochem Res; 2016 Oct 05; 41(10):2797-2809. PubMed ID: 27412117
    [Abstract] [Full Text] [Related]

  • 14. Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.
    Conner TM, Nikolian VC, Georgoff PE, Pai MP, Alam HB, Sun D, Reed RC, Zhang T.
    Eur J Pharm Sci; 2018 Jan 01; 111():465-481. PubMed ID: 29030176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS, Lee YJ, Kim BJ, Shin KJ, Chung BC, Baek DJ, Jung BH.
    Arch Pharm Res; 2009 Jul 01; 32(7):1029-35. PubMed ID: 19641884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS, Mahajan MS, Nerkar PP, Agrawal A.
    Drug Deliv; 2014 Mar 01; 21(2):148-54. PubMed ID: 24128122
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.